Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liver.
Level 5 - mechanism / opinion, no new human data
Preclinical in vitro cell culture and in vivo animal experiment
PubMed 23152807 · doi:10.1371/journal.pone.0048801
What was done
The authors investigated the regulatory interactions between AMP deaminase 2 (AMPD2) and AMP-activated protein kinase (AMPK) in hepatic steatosis. In cultured human hepatocytes, they altered AMPD2 and AMPK expression and activity using overexpression, gene silencing, and fructose exposure to reduce intracellular phosphate. They also examined whether uric acid directly affects AMPK activity. In vivo, they evaluated liver fat accumulation, AMPD activity, and AMPK activity in sucrose-fed rats with or without metformin treatment.
What was found
The abstract reports no numerical data or statistical confidence intervals. Qualitatively, AMPD2 activation (via overexpression or fructose) reduced AMPK activity in human hepatocytes, whereas AMPK silencing increased AMPD activity. Uric acid inhibited AMPK activity in hepatocytes. In AMPD2-deficient hepatocytes, fructose exposure further activated AMPK and increased fatty acid oxidation, while AMPK silencing increased AMPD-dependent fat accumulation. In vivo, sucrose-induced fatty liver in rats was prevented by metformin, which decreased AMPD activity and increased AMPK activity.
Why it matters
The study identifies a counter-regulatory pathway where AMPD2 and downstream uric acid inhibit AMPK activity, promoting hepatic fat accumulation. This provides a mechanistic explanation linking high sugar intake and nucleotide turnover to the pathogenesis of fatty liver disease.
Limits
The study is entirely preclinical, relying on cell culture models and rodent feeding experiments. The abstract lacks sample sizes, effect sizes, statistical bounds, experimental durations, and exposure concentrations. Findings cannot be directly extrapolated to clinical human outcomes.
Cited by
- supports Uric acid directs energy metabolism away from AMP-activated protein kinase (AMPK) and into AMP deaminase, promoting lipogenesis.